Skip to content

Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation

Evaluation of Voice Analysis Technology in Detecting and Managing Depression and Anxiety in Patients Undergoing Cardiac Rehabilitation

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05371470
Enrollment
200
Registered
2022-05-12
Start date
2023-09-21
Completion date
2026-11-01
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Cardiac Rehabilitation

Brief summary

The purpose of this study is to learn if a voice analysis smartphone app which detects anxiety and depression could be used along with cardiac rehabilitation to improve results compared to cardiac rehabilitation alone.

Interventions

DEVICEEllipsis Health Voice Application

Smartphone application that utilizes voice biomarkers to assess for potential presence and severity of depression and anxiety

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. ≥ 18 years 2. Enrolled in cardiac rehabilitation program to start within 3 months from hospital discharge 3. Owns a smartphone 4. Willing to download and use a smartphone app 5. Able to read, write, and speak English

Exclusion criteria

1. Cardiac transplant 2. Active substance use 3. Neurocognitive disorder 4. Active psychosis 5. Mania diagnosis 6. Active suicidality 7. Uncontrolled bipolar disorder

Design outcomes

Primary

MeasureTime frameDescription
Change in depressive symptomsBaseline, 12 weeksMeasured using the self-reported Patient Health Questionnaire-9 (PHQ-9) to assess for major depressive disorder. Possible score range from 0 to 27, with higher scores indicating a worse outcome/greater severity of depressive symptoms.
Change in anxiety symptomsBaseline, 12 weeksMeasured using the self-reported Generalized Anxiety Disorder 7-Item Scale (GAD-7) that assesses anxiety symptoms. Possible score range from 0 to 21, with higher scores indicating a worse outcome/greater severity of anxiety symptoms.
Change in perceived stressBaseline, 12 weeksMeasured using the self-reported Perceived Stress Scale-14 (PSS-14), a 14 item questionnaire which assesses the degree to which situations in life are stressful within the last month. Each item is scored on a 5 point Likert scale from 0 (never) to 4 (very often), higher total scores indicate a worse outcome/greater severity of perceived stress.
Change in quality of lifeBaseline, 12 weeksMeasured using the self-reported abbreviated generic Quality of Life Scale developed through the World Health Organization (WHOQOL-BREF) questionnaire that assesses an individual's perceptions of their health and well-being within the last two weeks. Each item is scored on a 5 point Likert scale, higher scores indicate greater perceived quality of life.
Change in health behaviorsBaseline, 12 weeksMeasured using the self-reported Current Health Behaviors (HB) questionnaire, a 13 item questionnaire which assesses behaviors and life circumstances during the last month. Each item is scored on a 10 point Likert scale, higher scores indicate better outcome.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORVirend Somers, MD, PhD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026